6.83
price down icon6.82%   -0.50
after-market 시간 외 거래: 6.70 -0.13 -1.90%
loading
전일 마감가:
$7.33
열려 있는:
$7.17
하루 거래량:
2.31M
Relative Volume:
1.21
시가총액:
$1.16B
수익:
$177.28M
순이익/손실:
$-195.24M
주가수익비율:
-5.097
EPS:
-1.34
순현금흐름:
$-114.54M
1주 성능:
-12.66%
1개월 성능:
-18.69%
6개월 성능:
+50.11%
1년 성능:
+184.58%
1일 변동 폭
Value
$6.7747
$7.39
1주일 범위
Value
$6.7747
$8.01
52주 변동 폭
Value
$2.36
$9.01

Adaptive Biotechnologies Corp Stock (ADPT) Company Profile

Name
명칭
Adaptive Biotechnologies Corp
Name
전화
206-659-0067
Name
주소
1165 EASTLAKE AVE E, SEATTLE, WA
Name
직원
619
Name
트위터
@adaptivebiotech
Name
다음 수익 날짜
2025-02-11
Name
최신 SEC 제출 서류
Name
ADPT's Discussions on Twitter

ADPT을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
ADPT
Adaptive Biotechnologies Corp
6.83 1.16B 177.28M -195.24M -114.54M -1.34
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
477.52 127.47B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
561.49 62.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
595.70 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
232.75 31.06B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
229.22 26.16B 3.81B -644.79M -669.77M -6.24

Adaptive Biotechnologies Corp Stock (ADPT) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-03-21 업그레이드 Goldman Neutral → Buy
2023-07-05 재개 JP Morgan Overweight
2023-01-05 개시 Scotiabank Sector Outperform
2022-12-21 업그레이드 Piper Sandler Neutral → Overweight
2022-08-25 개시 Credit Suisse Underperform
2022-06-03 개시 Piper Sandler Neutral
2022-02-16 재확인 BTIG Research Buy
2022-02-16 재확인 BofA Securities Buy
2022-02-16 재확인 Goldman Neutral
2022-02-16 재확인 JP Morgan Overweight
2021-10-15 재개 Cowen Outperform
2021-03-03 다운그레이드 Goldman Buy → Neutral
2020-10-08 재개 BTIG Research Buy
2020-09-09 개시 Morgan Stanley Equal-Weight
2020-06-03 개시 Goldman Buy
2019-07-23 개시 BTIG Research Buy
2019-07-22 개시 BofA/Merrill Buy
2019-07-22 개시 Cowen Outperform
2019-07-22 개시 Goldman Neutral
2019-07-22 개시 Guggenheim Buy
2019-07-22 개시 William Blair Outperform
모두보기

Adaptive Biotechnologies Corp 주식(ADPT)의 최신 뉴스

pulisher
04:25 AM

Insider ROBINS HARLAN S sells 1,698 of Adaptive Biotechnologies Corp [ADPT] Stock - knoxdaily.com

04:25 AM
pulisher
11:33 AM

JPMorgan Chase & Co. Lowers Stock Holdings in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World

11:33 AM
pulisher
Apr 20, 2025

Alliancebernstein L.P. Sells 1,890 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World

Apr 20, 2025
pulisher
Apr 20, 2025

Federated Hermes Inc. Reduces Stock Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World

Apr 20, 2025
pulisher
Apr 18, 2025

Franklin Resources Inc. Invests $443,000 in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World

Apr 18, 2025
pulisher
Apr 11, 2025

Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025 | ADPT Stock News - GuruFocus

Apr 11, 2025
pulisher
Apr 11, 2025

Corebridge Financial Inc. Has $345,000 Holdings in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World

Apr 11, 2025
pulisher
Apr 10, 2025

Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025 - The Manila Times

Apr 10, 2025
pulisher
Apr 09, 2025

25,800 Shares in Adaptive Biotechnologies Co. (NASDAQ:ADPT) Acquired by KLP Kapitalforvaltning AS - Defense World

Apr 09, 2025
pulisher
Apr 08, 2025

Adaptive Biotechnologies' Mantle Cell Lymphoma Test Receives Expanded Medicare Coverage - MarketScreener

Apr 08, 2025
pulisher
Apr 08, 2025

Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Surveillance in Mantle Cell Lymphoma - The Manila Times

Apr 08, 2025
pulisher
Apr 08, 2025

Minimal Residual Disease Testing Market Forecast Report, 2025-2030 - GlobeNewswire Inc.

Apr 08, 2025
pulisher
Apr 04, 2025

Guess, Tesla, Nvidia And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga

Apr 04, 2025
pulisher
Apr 04, 2025

Why Sangamo Therapeutics Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket - Benzinga

Apr 04, 2025
pulisher
Apr 02, 2025

12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga

Apr 02, 2025
pulisher
Mar 30, 2025

Swiss National Bank Takes $1.22 Million Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World

Mar 30, 2025
pulisher
Mar 29, 2025

Proficio Capital Partners LLC Takes Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World

Mar 29, 2025
pulisher
Mar 28, 2025

Adaptive Biotechnologies Corp: Analyzing ADPT Stock Trends - investchronicle.com

Mar 28, 2025
pulisher
Mar 28, 2025

Adaptive Biotechnologies (NASDAQ:ADPT) Hits New 12-Month HighShould You Buy? - MarketBeat

Mar 28, 2025
pulisher
Mar 27, 2025

Adaptive Biotechnologies’ chief scientific officer sells shares for $15,282 By Investing.com - Investing.com Australia

Mar 27, 2025
pulisher
Mar 26, 2025

Adaptive Biotechnologies’ chief scientific officer sells shares for $15,282 - Investing.com India

Mar 26, 2025
pulisher
Mar 25, 2025

Charles Schwab Investment Management Inc. Acquires 39,831 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World

Mar 25, 2025
pulisher
Mar 24, 2025

Adaptive Biotechnologies stock hits 52-week high at $8.95 By Investing.com - Investing.com Australia

Mar 24, 2025
pulisher
Mar 24, 2025

Adaptive Biotechnologies stock hits 52-week high at $8.95 - Investing.com

Mar 24, 2025
pulisher
Mar 23, 2025

Amundi Boosts Stake in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World

Mar 23, 2025
pulisher
Mar 23, 2025

Adaptive Biotechnologies (NASDAQ:ADPT) Shares Gap Up – What’s Next? - Defense World

Mar 23, 2025
pulisher
Mar 23, 2025

Adaptive Biotechnologies (NASDAQ:ADPT) Stock Rating Upgraded by The Goldman Sachs Group - Defense World

Mar 23, 2025
pulisher
Mar 22, 2025

Bank of New York Mellon Corp Has $2.18 Million Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World

Mar 22, 2025
pulisher
Mar 21, 2025

Adaptive Biotechnologies Gains Following Goldman Sachs Upgrade, Share Climb 6% Near Friday Close - MarketScreener

Mar 21, 2025
pulisher
Mar 21, 2025

Analyst Expectations For Adaptive Biotechnologies's Future - Benzinga

Mar 21, 2025
pulisher
Mar 21, 2025

Scholastic Posts Strong Earnings, Joins Ouster, Torrid Holdings, Adaptive Biotechnologies And Other Big Stocks Moving Higher On Friday - Benzinga

Mar 21, 2025
pulisher
Mar 21, 2025

Goldman Sachs Upgrades Adaptive Biotechnologies to Buy From Neutral, Adjusts Price Target to $9 From $8 - Marketscreener.com

Mar 21, 2025
pulisher
Mar 21, 2025

Goldman Sachs lifts Adeptus Biotech stock rating to Buy, target to $9 - Investing.com

Mar 21, 2025
pulisher
Mar 20, 2025

Adaptive Biotechnologies (ADPT): Among Stocks Insiders Are Selling In March - Insider Monkey

Mar 20, 2025
pulisher
Mar 17, 2025

10 Stocks Insiders Are Selling In March - Insider Monkey

Mar 17, 2025
pulisher
Mar 14, 2025

Proficio Capital Partners LLC Takes $93,000 Position in Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World

Mar 14, 2025
pulisher
Mar 14, 2025

Critical Survey: Adaptive Biotechnologies (NASDAQ:ADPT) vs. Beam Therapeutics (NASDAQ:BEAM) - Defense World

Mar 14, 2025
pulisher
Mar 12, 2025

Adaptive Biotechnologies director sells shares worth $70,500 By Investing.com - Investing.com Canada

Mar 12, 2025
pulisher
Mar 12, 2025

Adaptive Biotechnologies director sells shares worth $70,500 - Investing.com India

Mar 12, 2025
pulisher
Mar 12, 2025

Adaptive Biotechnologies director sells shares worth $402,270 - Investing.com

Mar 12, 2025
pulisher
Mar 12, 2025

Adaptive Biotechnologies Executives Sell Shares - TradingView

Mar 12, 2025
pulisher
Mar 12, 2025

Minimal Residual Disease Market Expected to rise, 2032 | Adaptive Biotechnologies, Bristol-Myers Squibb Company, Natera, Kite Pharma, Amgen Inc., expected to boost the market - Barchart

Mar 12, 2025
pulisher
Mar 11, 2025

Adaptive Biotechnologies Launches Assay Enhancements to Increase clonoSEQ® Sensitivity for Clinical MRD Detection in Diffuse Large B-Cell Lymphoma - The Manila Times

Mar 11, 2025
pulisher
Mar 11, 2025

US Bancorp DE Sells 43,819 Shares of Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World

Mar 11, 2025
pulisher
Mar 11, 2025

Revolutionary 7x Sensitivity Boost: Adaptive's New Cancer Detection Test Transforms Lymphoma Monitoring - Stock Titan

Mar 11, 2025
pulisher
Mar 09, 2025

Insider Selling: Adaptive Biotechnologies Co. (NASDAQ:ADPT) CEO Sells $819,109.98 in Stock - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

Adaptive Biotechnologies (NASDAQ:ADPT) Stock Price Down 6.5% on Insider Selling - Defense World

Mar 08, 2025
pulisher
Mar 08, 2025

Adaptive Biotechnologies director sells $124,372 in stock By Investing.com - Investing.com Australia

Mar 08, 2025
pulisher
Mar 07, 2025

Adaptive Biotechnologies CEO Chad Robins sells $1.6 million in stock By Investing.com - Investing.com Australia

Mar 07, 2025
pulisher
Mar 07, 2025

Adaptive Biotechnologies’ chief commercial officer Sharon Benzeno sells $311,792 in stock By Investing.com - Investing.com South Africa

Mar 07, 2025
pulisher
Mar 07, 2025

Principal Financial Group Inc. Purchases Shares of 143,444 Adaptive Biotechnologies Co. (NASDAQ:ADPT) - Defense World

Mar 07, 2025

Adaptive Biotechnologies Corp (ADPT) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.07
price up icon 0.15%
$69.51
price down icon 4.32%
$32.19
price down icon 1.26%
$25.22
price up icon 2.48%
$101.81
price up icon 3.09%
biotechnology ONC
$229.22
price down icon 0.76%
자본화:     |  볼륨(24시간):